by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

BioMylz Pvt. Ltd. Warning Letter Details

Warning Letter

BioMylz Pvt. Ltd.

# cj-1, Santra Magan Place Apartment off Banneraghatta Road Doddakammanahalli, near Maruthi Dental College Bangalore 560076 India

Issue DateJuly 13, 2026

FEI Number3013697420

Violations6

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated/Misbranded

BioMylz Pvt. Ltd. FDA Warning Letter, July 13, 2026